Evidence map›Paper›PMID 29158283›Full record

ArticleAntimicrobial agents and chemotherapy2018

Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.

Jessica L Chitty, Mark S Butler, Azzah Suboh, David J Edwards, Matthew A Cooper, James A Fraser, Avril A B Robertson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jessica L ChittyAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
Mark S ButlerInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
Azzah SubohInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
David J EdwardsInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
Matthew A CooperAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
James A FraserAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
Avril A B RobertsonInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia avril.robertson@imb.uq.edu.au.ORCID 0000-0002-9652-8357

Funding

Discovery of Polymyxin-based Antibacterial Agents Active Against Multi-Drug ResisR33AI098731 · NIAID · UNIVERSITY OF QUEENSLAND · PI COOPER, MATTHEW A, LASH, LAWRENCE H. · 2014 to 2016
$945k
NIAID NIH HHS R33 AI098731
6 · The paper itself

Abstract

Resistance to antimicrobials is a growing problem in both developed and developing countries. In nations where AIDS is most prevalent, the human fungal pathogen

Indexed as

Amphotericin BAntifungal AgentsAspergillus fumigatusCandida albicansCandida glabrataCandida parapsilosisCryptococcus gattiiCryptococcus neoformansDrug Resistance, FungalFluconazoleHumansLipopeptidesMicrobial Sensitivity TestsPeptides, CyclicStructure-Activity RelationshipAmphotericin BAntifungal AgentsFluconazoleLipopeptidesoctapeptin C4Peptides, Cyclicantifungal agentsCryptococcus neoformanslipopeptideoctapeptin

Identifiers

PMID29158283
PMCPMC5786788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.